Current Posts – 04 Mar 2014

Should many more of us be taking statins and if so what’s the evidence it is a good idea? NICE suggests that their guidelines should be changed to make millions more eligible for the drug. But they are basing their recommendation on the work of a far less well known body -The Cholesterol Trialist (CTT) Collaboration, a highly respected research group in Oxford.

An HealthInsightUK investigation – CTT House of statin secrets - has found the CTT is worryingly secretive and has limited information about side-effects.

HealthInsightUK has a number of contributors who are experts in statins. Here three of them – Dr John Briffa, Zoe Harcombe and Aidan Goggins respond to the CTT investigation. They explain why side-effect data is unreliable and disagree about whether it is in the drug companies interest that the risk of side-effects is downplayed or is that part of cunning plan?

Getting the cancer all-clear is obviously cause for celebration but for far too many survivors that is just the beginning. Living with the aftermath of cancer treatment can involve all sorts of health problems and the help and understanding available is totally inadequate. Mike Wakeman tells you what to expect, what to do about it and where to go for more help.

I thought I had uncovered a drug scandal that was killing 10,000 a year in the UK but I found it was more serious than that. It was a vivid example of how evidence based medicine can fail to work even when those involved are following the rules. It seems that when the evidence changes no one is really responsible for passing that information on.



Editor: Jerome Burne |

Latest posts by Editorial (see all)

Leave a Reply

WP-Backgrounds by InoPlugs Web Design and Juwelier Schönmann